A J Cohen

Summary

Affiliation: University of Colorado Health Sciences Center
Country: USA

Publications

  1. ncbi Low neutral endopeptidase levels in bronchoalveolar lavage fluid of lung cancer patients
    A J Cohen
    Department of Pathology, Denver Veterans Administration Medical Center University of Colorado Health Sciences Center National Jewish Center for Medicine and Research, Denver, Colorado, USA
    Am J Respir Crit Care Med 159:907-10. 1999
  2. ncbi Acupuncture: role in comprehensive cancer care--a primer for the oncologist and review of the literature
    Andrea J Cohen
    Division of Pulmonary Sciences and Critical Care Medicine, Division of Medical Oncology, University of Colorado Health Sciences Center, University of Colorado Cancer Center, Denver, CO 80262, USA
    Integr Cancer Ther 4:131-43. 2005
  3. ncbi Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo
    P A Bunn
    Division of Medical Oncology, University of Colorado Cancer Center, Denver 80262, USA
    Clin Cancer Res 4:2849-58. 1998
  4. ncbi Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux
    A J Cohen
    Division of Pulmonary Sciences, Denver Veterans Affairs Medical Center, Colorado, USA
    Cancer Res 56:831-9. 1996
  5. ncbi Hemorrhage and resuscitation alter the expression of ICAM-1 and P-selectin in mice
    R Shenkar
    Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver 80262, USA
    J Inflamm 45:248-59. 1995
  6. ncbi Point-counterpoint: using clinical trials for the evaluation of integrative cancer therapies
    Keith I Block
    Block Center for Integrative Cancer Care, Evanston, Illinois 60201, USA
    Integr Cancer Ther 3:66-81. 2004
  7. ncbi The challenges of randomized trials in integrative cancer care
    Keith I Block
    Block Center for Integrative Cancer Care, 1800 Sherman, Suite 515, Evanston IL 60201, USA
    Integr Cancer Ther 3:112-27. 2004

Collaborators

Detail Information

Publications7

  1. ncbi Low neutral endopeptidase levels in bronchoalveolar lavage fluid of lung cancer patients
    A J Cohen
    Department of Pathology, Denver Veterans Administration Medical Center University of Colorado Health Sciences Center National Jewish Center for Medicine and Research, Denver, Colorado, USA
    Am J Respir Crit Care Med 159:907-10. 1999
    ..Low NEP levels in the airways may be a factor in the pathogenesis of carcinoma of the lung...
  2. ncbi Acupuncture: role in comprehensive cancer care--a primer for the oncologist and review of the literature
    Andrea J Cohen
    Division of Pulmonary Sciences and Critical Care Medicine, Division of Medical Oncology, University of Colorado Health Sciences Center, University of Colorado Cancer Center, Denver, CO 80262, USA
    Integr Cancer Ther 4:131-43. 2005
    ..A majority of the current studies have shown beneficial effects that warrant further investigation with large trial sizes...
  3. ncbi Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo
    P A Bunn
    Division of Medical Oncology, University of Colorado Cancer Center, Denver 80262, USA
    Clin Cancer Res 4:2849-58. 1998
    ..Continuous exposure to high doses was required for growth inhibition. These studies confirm the importance of NEP in this autocrine pathway...
  4. ncbi Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux
    A J Cohen
    Division of Pulmonary Sciences, Denver Veterans Affairs Medical Center, Colorado, USA
    Cancer Res 56:831-9. 1996
    ..NEP, therefore, is a signal transduction and possibly a growth modulator for both SCLC and NSCLC, emphasizing the role of neuropeptides in the pathogenesis of the major histological forms of lung cancer...
  5. ncbi Hemorrhage and resuscitation alter the expression of ICAM-1 and P-selectin in mice
    R Shenkar
    Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver 80262, USA
    J Inflamm 45:248-59. 1995
    ....
  6. ncbi Point-counterpoint: using clinical trials for the evaluation of integrative cancer therapies
    Keith I Block
    Block Center for Integrative Cancer Care, Evanston, Illinois 60201, USA
    Integr Cancer Ther 3:66-81. 2004
  7. ncbi The challenges of randomized trials in integrative cancer care
    Keith I Block
    Block Center for Integrative Cancer Care, 1800 Sherman, Suite 515, Evanston IL 60201, USA
    Integr Cancer Ther 3:112-27. 2004